ARTICLE | Company News
Genzyme Transgenics, Fresenius AG deal
July 23, 2001 7:00 AM UTC
Fresenius exercised an option under a 1997 agreement to obtain for $3.8 million rights to market GZTC's recombinant human serum albumin (rhSA) in North America and Asia, except Japan (see BioCentury,...